Related Experiment Video
Updated: May 14, 2026

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
The expression of integrins is decreased in colon cancer cells treated with polysaccharide K
Keiko Aso1, Takanori Goi, Toshiyuki Nakazawa
1First Department of Surgery, University of Fukui, Yoshida-gun, Fukui, Japan.
Abstract:
Polysaccharide K (PSK), a protein-bound polysaccharide used as a non-specific immunotherapeutic agent, is said to improve the prognosis of malignant tumors such as colon cancer, but there have been few in‑depth investigations of its mechanism of action. In the present study, we investigated which genes in colon cancer cells themselves are regulated by PSK and what sort of action it exerts. Colon cancer cells were exposed to PSK in vitro and changes to their morphology and adhesive capacity were investigated, as were the changes in integrin expression that occurred. Exposure to PSK caused colon cancer cells to become spherical in morphology and investigation of their adhesion rate showed that it reduced adhesion to laminin, fibrinogen, collagen IV, collagen I and fibronectin. In terms of changes to molecules on the surface of cancer cells, there was reduced expression of integrin mRNA α and β, which are ligands for the proteins of basement membrane. An investigation of the adhesiveness of PSK-stimulated colon cancer cells to vascular endothelial cells also showed that the adhesion rate decreased significantly compared with cells not exposed to PSK. Suppression of integrin expression on the cell surface and reduced adhesion to vascular endothelial cells were observed as a novel mechanism of action of PSK on colon cancer cells.
Insights
Polysaccharide K (PSK) reduces colon cancer cell adhesion to various substrates and vascular endothelial cells. This novel mechanism involves suppressing integrin expression on cancer cell surfaces, potentially improving cancer prognosis.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Polysaccharide K (PSK) is an immunotherapeutic agent used for malignant tumors.
- Its precise mechanism of action in colon cancer remains under-investigated.
Purpose of the Study:
- To elucidate the genes regulated by PSK in colon cancer cells.
- To understand the specific actions PSK exerts on colon cancer cells.
Main Methods:
- In vitro exposure of colon cancer cells to PSK.
- Assessment of morphological and adhesive changes.
- Analysis of integrin expression (mRNA α and β).
- Evaluation of cancer cell adhesion to vascular endothelial cells.
Main Results:
- PSK induced spherical morphology in colon cancer cells.
- Reduced adhesion to laminin, fibrinogen, collagen IV, collagen I, and fibronectin.
- Decreased expression of integrin mRNA α and β.
- Significantly reduced adhesion of PSK-treated cells to vascular endothelial cells.
Conclusions:
- PSK suppresses integrin expression on colon cancer cell surfaces.
- PSK reduces the adhesion of colon cancer cells to vascular endothelial cells.
- These findings reveal a novel mechanism of PSK action in colon cancer.
Related Concept Videos
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Intracellular Signaling Affects Focal Adhesions
Some...
Selectins
Renewal of Intestinal Stem Cells
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

